To cite this paper use one of the standards below:
Introduction: Leydig cell tumor is an ovarian pure stromal ovarian neoplasm, characterized by the production of steroid hormones, usually in postmenopausal women. Lesions may be small and restricted to the ovary, but may cause symptoms of hyperandrogenism and virilization. Objectives: The main objective is to report a case of Leydig cell tumor diagnosed in a postmenopausal woman. Methods: This is an observational and retrospective study based on a single case of Leydig cell tumor from the Department of Pathology from Emílio Carlos Hospital. The sources of data collection involved the medical records and examination reports provided by the respective service and will involve the variables gender, age at diagnosis, procedures performed, histopathology of the lesion and immunohistochemistry (Ethics Committee approval: CEP/UNIFIPA number 5.910.052). Results: An 83-year-old woman was referred to the oncologic clinic due to the finding of uterine lesions on ultrasound examination. During investigation, tumor markers were requested, including the CA-125 marker, whose serial dosage was shown to be ascending (46.5 - 227 - 442.5, reference value up to 35 U/mL). Surgery was then proposed for total hysterectomy and bilateral salpingo oophorectomy, which occurred uneventfully. The uterus was enlarged and there was a moderate amount of ascitic fluid. Histopathologic examination identified a uterus with intramural nodules compatible with uterine leiomyomas, the largest measuring 5.0 x 4.0 cm. However, the right ovary showed the presence of a stromal neoplasm, measuring about 1.0 x 0.8 cm in its longest axes, composed of polygonal cells with large, eosinophilic and granular cytoplasm. Immunohistochemical study showed the lesion was positive for inhibin alpha and calretinin and FOXL2 was negative. The histopathological and immunohistochemical findings together allowed the diagnosis of ovarian Leydig cell tumor. Conclusions: Although a rare diagnosis, ovarian Leydig cell tumor should be an important differential diagnosis among ovarian neoplasms in postmenopausal women.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper